(Q35560203)

8 August 2017

1 reference

title

Mast cell proliferative disorders: current view on variants recognized by the World Health Organization (English)

1 reference

World Health Organization

8 August 2017

main subject

0 references

0 references

Cem Akin

2

0 references

Dean D. Metcalfe

series ordinal

5

object named as

Dean D Metcalfe

1 reference

8 August 2017

Peter Valent

1

1 reference

8 August 2017

Wolfgang R Sperr

series ordinal

3

1 reference

8 August 2017

Hans-Peter Horny

series ordinal

4

1 reference

8 August 2017

publication date

1 October 2003

1 reference

Hematology / Oncology Clinics of North America

8 August 2017

published in

1 reference

8 August 2017

volume

17

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

1227-1241

1 reference

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Surrogate markers of disease in mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

The riddle of the mast cell: kit(CD117)-ligand as the missing link?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Variable expression of activation-linked surface antigens on human mast cells in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Characterization of 'adult-type' mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chyma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Detection of novel CD antigens on the surface of human mast cells and basophils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Mast cell leukaemia: evidence for bone marrow origin of the pathological clone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Mast cells and mast cell neoplasia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Tissue mast cells in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Classification and diagnosis of mastocytosis: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Clinical and histopathological aspects of cutaneous mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Bone marrow findings in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Lymph node findings in generalized mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Spleen findings in generalized mastocytosis. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Liver findings in generalized mastocytosis. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

The liver, spleen, and lymph nodes in mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Significance of systemic mast cell disease with associated hematologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Diagnostic criteria and classification of mastocytosis: a consensus proposal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Diagnostic value of immunostaining for tryptase in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Mast cell leukemia: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Mastocytosis: mediator-related signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Cutaneous mastocytosis -- clinical heterogeneity.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Diffuse cutaneous mastocytosis with multiple cutaneous mastocytomas. Report of a case with clinical, histopathological and ultrastructural aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Telangiectasia macularis eruptiva perstans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Treatment of cutaneous mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Systemic mastocytosis with extensive large cutaneous mastocytomas: surgical management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Treatment of systemic mast cell disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Mast cell sarcoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

Solitary mast cell tumor of the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

A solitary manifestation of mastocytosis in the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900089-3

7 January 2021

10.1016/S0889-8588(03)00089-3

Identifiers

DOI

1 reference

8 August 2017

1 reference